These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 31243362)

  • 41. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [2-DE profiling and differential analysis of human bronchial epithelial tissues in different stages of carcinogenesis].
    Wu XY; Li C; Xiao ZQ; Li JL; Feng XP; Yi H; Li MY; Chen ZC
    Ai Zheng; 2004 May; 23(5):522-30. PubMed ID: 15142447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.
    Goldmann T; Marwitz S; Nitschkowski D; Krupar R; Backman M; Elfving H; Thurfjell V; Lindberg A; Brunnström H; La Fleur L; Mezheyeuski A; Mattsson JSM; Botling J; Micke P; Strell C
    Cancer Immunol Immunother; 2021 Sep; 70(9):2577-2587. PubMed ID: 33576873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
    Shang X; Li J; Wang H; Li Z; Lin J; Chen D; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106864. PubMed ID: 32866782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.
    Marzio A; Kurz E; Sahni JM; Di Feo G; Puccini J; Jiang S; Hirsch CA; Arbini AA; Wu WL; Pass HI; Bar-Sagi D; Papagiannakopoulos T; Pagano M
    Cell; 2022 Jan; 185(1):169-183.e19. PubMed ID: 34963055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
    Jiang Y; Zhan H
    Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical markers of proliferation and vascularisation in preneoplastic bronchial lesions and invasive non-small cell lung cancer.
    Cavarga I; Kocan P; Boor A; Belak J; Zak V; Kluchova Z; Slavik L; Tkacova R
    Neoplasma; 2009; 56(5):414-21. PubMed ID: 19580343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
    Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
    Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition.
    Giangreco A; Lu L; Vickers C; Teixeira VH; Groot KR; Butler CR; Ilieva EV; George PJ; Nicholson AG; Sage EK; Watt FM; Janes SM
    J Pathol; 2012 Mar; 226(4):575-87. PubMed ID: 22081448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
    Prat A; Navarro A; Paré L; Reguart N; Galván P; Pascual T; Martínez A; Nuciforo P; Comerma L; Alos L; Pardo N; Cedrés S; Fan C; Parker JS; Gaba L; Victoria I; Viñolas N; Vivancos A; Arance A; Felip E
    Cancer Res; 2017 Jul; 77(13):3540-3550. PubMed ID: 28487385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.
    Li X; Suo J; Shao S; Xue L; Chen W; Dong L; Shi J; Fu M; Lu N; Zhan Q; Tong T
    PLoS One; 2014; 9(3):e90958. PubMed ID: 24608342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.
    Filipska M; Skrzypski M; Czetyrbok K; Stokowy T; Stasiłojć G; Supernat A; Jassem J; Żaczek AJ; Bigda J
    Lung Cancer; 2018 Apr; 118():111-118. PubMed ID: 29571988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of microRNA expression during human bronchial squamous carcinogenesis.
    Mascaux C; Laes JF; Anthoine G; Haller A; Ninane V; Burny A; Sculier JP
    Eur Respir J; 2009 Feb; 33(2):352-9. PubMed ID: 19010987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaplastic transition within the cancer microenvironment in early-stage oral tongue squamous cell carcinoma is associated with local recurrence.
    Okuyama K; Suzuki K; Yanamoto S; Naruse T; Tsuchihashi H; Yamashita S; Umeda M
    Int J Oncol; 2018 Oct; 53(4):1713-1720. PubMed ID: 30085337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
    Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
    BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.